RESUMEN
OBJECTIVE: To evaluate the short term effects on nutritional status of home intravenous anti-pseudomonas antibiotic courses in cystic fibrosis (CF) patients chronically colonised with Pseudomonas aeruginosa. DESIGN: A prospective study involving 38 CF patients, mean age 10.9 (SD 4.3) years (range 4.3 to 22.2 years), presenting with pulmonary exacerbations of P aeruginosa infection. The patients received a 14 day antibiotic course of intravenous ceftazidime (200 mg/kg/day) and either amikacin (35 mg/kg/day) or tobramycin (15 mg/kg/day). Nutritional evaluation on days 1 and 14 involved measurements of weight, weight/height ratio (per cent of predicted value), energy intake (per cent of recommended daily allowances), serum prealbumin, and body composition assessed by two methods: bioelectrical analysis (BIA) and skinfold anthropometry. The non-parametric Wilcoxon t test was used for statistical analysis, with a Bland-Altman plot to assess the degree of agreement between the two methods of evaluating body composition. RESULTS: Weight increased by 1.0 (0.8) kg (p < 0.001); weight/height increased from 94.4(12.2)% to 98(12.7)% (p < 0.001), energy intake from 107(32)% to 119(41)% (p < 0.02), and prealbumin from 183 (63) to 276 (89) mg/l (p < 0.001). Fat mass increased by 0.8 (1.0) kg (p < 0.001), without any significant change in fat-free mass. The limits of agreement between BIA and anthropometry were -0.7 kg and +1.1 kg. CONCLUSIONS: Antibiotic courses allow an improvement in nutritional status in CF patients, with a gain in fat mass.
Asunto(s)
Fibrosis Quística/complicaciones , Quimioterapia Combinada/uso terapéutico , Estado Nutricional , Infecciones Oportunistas/tratamiento farmacológico , Infecciones por Pseudomonas/tratamiento farmacológico , Adolescente , Adulto , Amicacina/uso terapéutico , Antropometría , Composición Corporal , Ceftazidima/uso terapéutico , Niño , Preescolar , Enfermedad Crónica , Femenino , Humanos , Masculino , Infecciones Oportunistas/complicaciones , Estudios Prospectivos , Infecciones por Pseudomonas/complicaciones , Tobramicina/uso terapéuticoRESUMEN
UNLABELLED: Twenty cystic fibrosis patients aged 1.8-22 years (mean +/- SD: 9.6 +/- 4.8 years) with Pseudomonas aeruginosa pulmonary exacerbations were treated with amikacin (AM) (35 mg/kg/day in one daily 30 min infusion) associated with either ceftazidime (200 mg/kg/day in 3 i.v. injections) (n = 19) or imipenem (n = 1) at the same dose. Glomerular and tubular functions (creatinine clearance, 24-h proteinuria, beta 2 microglobulinuria, lysozymuria) and audiometry remained within normal ranges from day 0 to day 14. A peak concentration of AM of 83 +/- 19 mg/l and a trough concentration of 0.8 +/- 0.5 mg/l were observed in blood while AM levels in sputum were above the minimal inhibitory concentration 50 from 30 min to 16 h. No serum accumulation of AM was observed during the treatment. From day 0 to day 14, the following changes were observed: weight/height ratio: 96%-100% (P < 0.001); daily energy intake: 111%-128% of RDA (P < 0.001); prealbumin: 195-290 mg/l (P < 0.001); forced vital capacity (FVC): 66%-81% (P < 0.01); forced expiratory volume in 1 s: 60%-75% (P < 0.01); forced expiratory flow between 25% and 75% of FVC: 42%-56% (P < 0.01); nocturnal SaO2 also improved significantly; cardiac rate decreased from 89 +/- 18/min to 76 +/- 16/min (P < 0.001); respiratory rate decreased from 31 +/- 15/min to 26 +/- 10/min (P < 0.05); inflammatory parameters (white blood cells, polymorphonuclear cells, erythrocyte sedimentation rate) also improved. CONCLUSION: Once daily amikacin administration associated with ceftazidime is well tolerated for the treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients. Serum peak levels and diffusion in sputum are higher than with a conventional schedule.
Asunto(s)
Amicacina/uso terapéutico , Antibacterianos/uso terapéutico , Fibrosis Quística/tratamiento farmacológico , Neumonía Bacteriana/tratamiento farmacológico , Infecciones por Pseudomonas/tratamiento farmacológico , Adolescente , Adulto , Amicacina/administración & dosificación , Amicacina/farmacocinética , Antibacterianos/administración & dosificación , Antibacterianos/farmacocinética , Audiometría , Niño , Preescolar , Fibrosis Quística/complicaciones , Esquema de Medicación , Femenino , Humanos , Lactante , Pruebas de Función Renal , Masculino , Neumonía Bacteriana/complicaciones , Infecciones por Pseudomonas/complicacionesRESUMEN
We report a case of transient erythroblastopenia in a three-year-old girl presenting with echovirus 11 infection. Viral infection was demonstrated by isolation of echovirus 11 in stool cultures and the presence of echovirus 11-specific IgM antibody in serum. We suggest that echovirus may have played a role in the pathogenesis of transient erythroblastopenia of childhood in this patient.
Asunto(s)
Anemia/etiología , Infecciones por Echovirus/complicaciones , Eritroblastos , Anemia/sangre , Preescolar , Infecciones por Echovirus/sangre , Infecciones por Echovirus/microbiología , Enterovirus Humano B/aislamiento & purificación , Recuento de Eritrocitos , Femenino , Humanos , ReticulocitosRESUMEN
The serum kinetics of vancomycin was studied in two patients aged 3 and 15 years during antibiotic therapy for catheter related sepsis associated with Staphylococcus epidermidis. Vancomycin was administered, simultaneously, by parenteral conventional doses (30 mg/kg/day div q 8 h) and using the antibiotic-lock technique in the infected catheter at a high concentration (150 mg/ml) during one hour, 3 hours after each infusion. Pharmacokinetics data did not show any significant change in the serum kinetics of the antibiotic. The results suggest that delivering a high concentration of vancomycin in the infected catheter using the lock technique may be useful to sterilize infected catheter without toxic effect.
Asunto(s)
Cateterismo Venoso Central/efectos adversos , Vancomicina/farmacocinética , Adolescente , Bacteriemia/tratamiento farmacológico , Bacteriemia/etiología , Preescolar , Humanos , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/etiología , Staphylococcus epidermidis , Infección de la Herida Quirúrgica/tratamiento farmacológico , Infección de la Herida Quirúrgica/etiología , Vancomicina/administración & dosificación , Vancomicina/sangre , Vancomicina/uso terapéuticoRESUMEN
The authors report on a 24-year old patient with Blackfan-Diamond syndrome who developed a Hodgkin's disease. This patient became transfusion-dependent at the age of 10, after an initial period of corticosensitivity, and after failure of androgens. He developed hemochromatosis despite from parenteral chelation therapy. He died of infectious complications 4 months after the diagnosis of Hodgkin's lymphoma. A review of the literature shows an increased incidence of malignancies in Blackfan-Diamond syndrome (three cases of leukemia), and in similar disease (thalassemia and sickle cell disease), but not in other patients with hemosiderosis (primitive hemochromatosis, end-stage renal failure under dialysis). Etiopathogenic hypotheses are discussed.
Asunto(s)
Anemia de Fanconi/complicaciones , Enfermedad de Hodgkin/etiología , Adulto , Anemia de Fanconi/terapia , Enfermedad de Hodgkin/epidemiología , Humanos , Masculino , Factores de RiesgoRESUMEN
Glioblastomas and medulloblastomas are models for studying the implication of growth factors and oncogenes in tumor development. Amplification and/or hyperexpression of oncogenes result in products that may mimic growth factors and/or their receptors; cells may demonstrate autocrine and/or paracrine activity. Prognostic implications of such findings are suggested.
Asunto(s)
Neoplasias Encefálicas/fisiopatología , Ganglioneuroma/fisiopatología , Sustancias de Crecimiento/fisiología , Meduloblastoma/fisiopatología , Oncogenes/fisiología , Línea Celular , Niño , HumanosRESUMEN
The authors report on a pediatric case of transient neutropenia with erythroblastopenia secondary to human parvovirus infection occurring in a child without underlying hemolytic disease. The heterogeneity of hematologic manifestations in such infections is discussed.
Asunto(s)
Anemia Aplásica/etiología , Eritema Infeccioso/complicaciones , Neutropenia/etiología , Niño , Eritema Infeccioso/diagnóstico , Femenino , HumanosRESUMEN
Alexander disease, or hypoproconvertinemia is a rare autosomic recessive coagulation disorder. The features include familial and/or personal history of bleeding, with an abnormal prothrombin period and a normal activated partial thromboplastin period. Coagulation and genetic studies allow subclassification with prognosis incidence for this disease. The authors report on a case of one family with Alexander disease.